Rituxan (rituximab) - Roche
Adult-Onset IgA Vasculitis With Concurrent Gastrointestinal and Possible Coronary Involvement. (PubMed, Cureus) - Sep 27, 2026 - "Despite treatment with oral and intravenous corticosteroids, his condition deteriorated, prompting escalation to rituximab, after which he initially improved and was discharged...Within days, he suffered a ventricular fibrillation arrest and passed away despite resuscitation efforts. This case highlights the aggressive trajectory of adult-onset IgA vasculitis, the potential for severe GI involvement, the considerable diagnostic difficulty in attributing subsequent cardiac events, especially with pre-existing cardiovascular disease, and the urgent need for clearer treatment strategies in severe presentations." 
Journal • Cardiovascular • Critical care • Gastrointestinal Disorder • Glomerulonephritis • IgA Nephropathy • Inflammation • Inflammatory Bowel Disease • Musculoskeletal Pain • Myocardial Infarction • Pain • Pediatrics • Renal Disease • Vasculitis
http://www.ncbi.nlm.nih.gov/pubmed/42799210
 
Antoni Chan; Maymuna Suleman; Shiva Chauhan
 
Sep 27, 2026
 
Prev Next